dacarbazine and Pancreatic Neoplasms

dacarbazine has been researched along with Pancreatic Neoplasms in 75 studies

Research

Studies (75)

Timeframe	Studies, this research(%)	All Research%
pre-1990	21 (28.00)	18.7374
1990's	6 (8.00)	18.2507
2000's	15 (20.00)	29.6817
2010's	31 (41.33)	24.3611
2020's	2 (2.67)	2.80

Authors

Authors	Studies
Apostolidis, L; Ettrich, TJ; Gress, TM; Hörsch, D; Jann, H; Kegel, T; König, A; Krug, S; Michl, P; Richter, M; Rinke, A; Schrader, J; Steighardt, J	1
Raj, N; Reidy-Lagunes, D; Wu, YL	1
Caroli-Bosc, FX; Cauchin, E; Dumars, C; Foubert, F; Girot, P; Matysiak-Budnik, T; Mosnier, JF; Muzellec, L; Regenet, N; Senellart, H; Touchefeu, Y	1
Allen, PJ; Basturk, O; Capanu, M; Chou, JF; Do, RKG; Horvat, N; Klimstra, DS; Raj, N; Reidy-Lagunes, D; Zhang, L	1
Carilli, A; Pellini Ferreira, B; Vasquez, J	1
Dureja, S; Gupta, SK; Kumar, S; Kumari, J; Malasani, V; Pant, V; Sen, I; Thakral, P; Un, P	1
Bai, CM; Cheng, YJ; Gao, X; Meng, CT; Yan, XY; Ying, HY; Zhou, JF; Zhou, N	1
Brixi, H; Cadiot, G; Cros, J; de Boissieu, P; de Mestier, L; Evrard, C; Hammel, P; Hentic, O; Legoux, JL; Lombard-Bohas, C; Rebours, V; Ruszniewski, P; Tougeron, D; Walter, T	1
Costa, FP; Gumz, B; Pasche, B	1
Allen, J; Blaszkowsky, L; Chan, JA; Gonzalez, M; Kulke, MH; Meyerhardt, J; Regan, E; Ryan, DP; Stuart, K; Wadlow, R; Zheng, H; Zhu, AX	1
Brennan, M; Garcon, MC; Kaley, K; Rodriguez, G; Rodriguez, T; Saif, MW	1
Saif, MW; Tejani, MA	1
Claringbold, PG; Kesavan, M; Turner, JH	1
Blank, A; Dawson, H; Komminoth, P; Pavel, M; Perren, A; Rudolph, T; Schmitt, AM; Vassella, E	1
Rashidi, A; Sorscher, SM	1
Ikeda, M; Kondo, S; Mitsunaga, S; Morizane, C; Ohno, I; Okusaka, T; Sakamoto, Y; Shimizu, S; Takahashi, H; Ueno, H	1
Claringbold, PG; Turner, JH	1
Borghi, D; Busel, AA; Caprera, F; Casale, E; Ciomei, M; Cirla, A; Corti, E; D'Anello, M; Donati, D; Fasolini, M; Felder, ER; Forte, B; Galvani, A; Isacchi, A; Khvat, A; Krasavin, MY; Lupi, R; Montagnoli, A; Orsini, P; Papeo, G; Perego, R; Pesenti, E; Pezzetta, D; Posteri, H; Rainoldi, S; Riccardi-Sirtori, F; Scolaro, A; Sola, F; Zuccotto, F	1
Arcella, A; Ascierto, PA; Cicala, D; De Divitiis, C; Grimaldi, AM; Iaffaioli, RV; Romano, GM; Simeone, E; Tafuto, S; Tatangelo, F; von Arx, C	1
Bedossa, P; Couvelard, A; Cros, J; Gille, N; Hammel, P; Hentic, O; Lévy, P; Maire, F; Paradis, V; Rebours, V; Ruszniewski, P; Theou-Anton, N; Vernerey, D; Zappa, M	1
Gress, TM; Krug, S; Majumder, M; Mueller, D; Rinke, A	1
Black, M; Brelsford, M; Cives, M; Ghayouri, M; Meeker, A; Morse, B; Rizzo, A; Strosberg, J	1
Black, PM; Bracht, LK; Drappatz, J; Hornick, JL; Kesari, S; Kulke, MH; LaFrankie, DC; Meyerhardt, JA; Norden, A; Redston, M; Wen, P	1
Clark, JW; Enzinger, PC; Frauenhoffer, C; Fuchs, CS; Hooshmand, S; Hornick, JL; Kulke, MH; Meyerhardt, JA; Redston, MS; Ryan, DP; Stuart, K	1
Abood, GJ; Go, A; Malhotra, D; Shoup, M	1
de Mestier, L; Dove, P; Hammel, P; Hentic, O; Lévy, P; Ruszniewski, P	1
Chen, DT; Choi, J; Coppola, D; Fine, RL; Helm, J; Kvols, L; Nasir, A; Strosberg, JR	1
Bruneton, D; Cassier, PA; Chayvialle, JA; Hervieu, V; Lombard-Bohas, C; Pilleul, F; Scoazec, JY; Walter, T	1
Ahmed, MM; Gupta, S; Sathishkumar, S	1
Reidy-Lagunes, D; Thornton, R	1
Barlier, A; Barrie, M; Brue, T; Castinetti, F; Conte-Devolx, B; Dufour, H; Morange, I; Philippon, M; Taieb, D	1
Dreyer, C; Faivre, S; Raymond, E	1
Degenhardt, YY; Diskin, SJ; Haglund, E; Maris, JM; Mayes, PA; Moy, C; Toporovskya, Y; Wood, A; Wooster, R	1
Federspiel, B; Hansen, CP; Kjaer, A; Knigge, U; Langer, SW; Olsen, IH; Sørensen, JB	1
Igarashi, H; Ito, T; Jensen, RT; Takayanagi, R	1
Enk, AH; Gronau, M; Hassel, JC; Jäger, D	1
Camp, R; Hemming, AW; Lind, DS	1
Ahmed, MM; Chendil, D; Kokkinakis, DM; Moschel, RC; Pegg, AE	1
Kokkinakis, DM; Liu, X; Neuner, RD	1
Arnold, R; Hofbauer, L; Rinke, A; Schmidt, Ch	1
Clark, JW; Enzinger, PC; Fuchs, CS; Kulke, MH; Michelini, A; Muzikansky, A; Ryan, DP; Stuart, K; Vincitore, M	1
Holen, K	1
Hayashi, H; Igarashi, H; Ito, T; Kawabe, K; Kodama, M; Sakai, H; Takayanagi, R; Yoshinaga, M	1
Lefebvre, PJ; Luyckx, AS	1
Fujita, J; Imura, H; Ishida, H; Kurose, T; Matsukura, M; Seino, Y; Taminato, T	1
Duncan, LA; Fagadau, WR; Marynick, SP	1
Awrich, AE; Fletcher, WS; Peetz, M	1
Badrinath, K; Banerji, M; Dorsch, TR; Lawrence, AM; Prinz, RA; Sparagana, M	1
Duncan, LA; Marynick, SP	1
Foley, JF; Kessinger, A; Lemon, HM	1
Keller, FS; Lieberman, DA; Rösch, J; Wawrukiewicz, AS	1
Dymling, JF; Hallengren, B; Manhem, P; Tennvall, L; Tibblin, S	1
Galle, K; Schweiss, D	1
Kemeny, N	1
Bloom, SR; Hammond, PJ	1
Strohm, WD	1
Feld, R; Hedley, D; Moore, MJ; Oza, A; Siu, LL	1
Hosotani, R; Imamura, M; Kubota, N; Ochi, J; Ohshio, G; Sakahara, H	1
Bassi, C; Bonora, A; Falconi, M; Mansueto, GC; Pederzoli, P; Procacci, C; Sartori, N; Talamini, G	1
Certin, M; D'Alteroche, L; Debbabi, S; Maillard, H; Metman, EH; Viguier, J	1
Mitry, E; Rougier, P	1
Carbone, PP; Cnaan, A; Hahn, RG; Haller, DG; Ramanathan, RK	1
Bajetta, E; Beretta, E; Bombardieri, E; Buzzoni, R; Catena, L; Celio, L; Di Bartolomeo, M; Ferrari, L; Ferrario, E; Martinetti, A; Procopio, G; Seregni, E; Vitali, M	1
Bos, LP; Erdkamp, FL; Knibbeler-van Rossum, CT; Peters, FJ	1
Aoki, TT; Strauss, GM; Weitzman, SA	1
Cruz, AB; Davis, HL; Fletcher, WS; Golomb, FM; Grage, T; Hill, GJ; Johnson, RO; Metter, G; Wilson, WL	1
Totsuka, Y	1
Altimari, AF; Badrinath, K; Prinz, RA; Reisel, HJ	1
Lambrecht, ER; van der Eerden, AH; van der Loos, TL	1
Bonvalet, D; Civatte, J; Jeanmougin, M; Passa, P; Verola, O; Zylberait, D	1
Fujita, J; Horio, T; Imamura, S; Ishida, H; Matsukura, S; Naito, A; Seino, Y; Takahashi, K; Taminato, T; Tobe, T	1
Altimari, AF; Bhoopalam, N; Lange, CL; O'Dorsio, T; Prinz, RA; Sandberg, L	1
Benson, JB; Ferrara, JJ; Fucci, JC	1
Lambers, JC; Lambrecht, ER; van der Loos, TL	1
Buck, M; Kvols, LK	1

Reviews

11 review(s) available for dacarbazine and Pancreatic Neoplasms

Article	Year
Selecting patients for cytotoxic therapies in gastroenteropancreatic neuroendocrine tumours. Best practice & research. Clinical gastroenterology, 2012, Volume: 26, Issue:6 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cell Proliferation; Dacarbazine; Deoxycytidine; Fluorouracil; Humans; Intestinal Neoplasms; Neoplasm Grading; Neoplasm Staging; Neuroendocrine Tumors; Pancreatic Neoplasms; Patient Selection; Prognosis; Stomach Neoplasms; Streptozocin; Temozolomide	2012
Cytotoxic chemotherapy for pancreatic neuroendocrine tumors. Journal of hepato-biliary-pancreatic sciences, 2015, Volume: 22, Issue:8 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Dacarbazine; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Streptozocin; Temozolomide	2015
The surgical and systemic management of neuroendocrine tumors of the pancreas. The Surgical clinics of North America, 2009, Volume: 89, Issue:1 Topics: Antineoplastic Agents, Alkylating; Carcinoma, Neuroendocrine; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality Therapy; Dacarbazine; Gastrinoma; Humans; Insulinoma; Liver Neoplasms; Octreotide; Pancreatic Neoplasms; Somatostatin; Vipoma	2009
Pancreatic neuroendocrine and carcinoid tumors: what's new, what's old, and what's different? Current oncology reports, 2012, Volume: 14, Issue:3 Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Carcinoid Tumor; Combined Modality Therapy; Dacarbazine; Embolization, Therapeutic; Everolimus; Humans; Immunosuppressive Agents; Indoles; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Sirolimus; Streptozocin; Sunitinib; Temozolomide; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factors; Yttrium Radioisotopes	2012
[Current status and therapeutic strategy for pancreatic neuroendocrine tumors in Japan]. Fukuoka igaku zasshi = Hukuoka acta medica, 2012, Volume: 103, Issue:7 Topics: Antineoplastic Agents; Dacarbazine; Digestive System Surgical Procedures; Everolimus; Humans; Immunosuppressive Agents; Indoles; Japan; Molecular Targeted Therapy; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Randomized Controlled Trials as Topic; Sirolimus; Somatostatin; Streptozocin; Sunitinib; Temozolomide	2012
Endocrine tumours of the gastrointestinal tract: Chemotherapy. Best practice & research. Clinical gastroenterology, 2005, Volume: 19, Issue:4 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cell Differentiation; Dacarbazine; Disease Progression; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; Streptozocin	2005
Therapeutic and palliative options for diffuse neuroendocrine metastatic disease. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2006, Volume: 10, Issue:3 Topics: Antineoplastic Agents; Dacarbazine; Humans; Immunologic Factors; Neoplasm Metastasis; Neuroendocrine Tumors; Nitrosourea Compounds; Palliative Care; Pancreatic Neoplasms; Somatostatin	2006
[The glucagonomas (author's transl)]. Diabete & metabolisme, 1981, Volume: 7, Issue:4 Topics: Adenoma, Islet Cell; Adult; Aged; Amino Acids; Anemia; Arginine; Body Weight; Cholesterol; Dacarbazine; Diabetes Mellitus; Diagnosis, Differential; Erythema; Female; Glossitis; Glucagon; Glucagonoma; Humans; Hypoproteinemia; Male; Middle Aged; Nervous System Diseases; Pancreatic Neoplasms; Somatostatin; Streptozocin; Thrombophlebitis; Zinc	1981
The systemic chemotherapy of hepatic metastases. Seminars in oncology, 1983, Volume: 10, Issue:2 Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Colonic Neoplasms; Dacarbazine; Drug Therapy, Combination; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Pancreatic Neoplasms; Rectal Neoplasms; Semustine; Stomach Neoplasms	1983
Chemotherapy in the treatment of neuroendocrine malignant tumors. Digestion, 2000, Volume: 62 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Doxorubicin; Etoposide; Fluorouracil; Gastrointestinal Neoplasms; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Streptozocin	2000
Chemotherapy of metastatic carcinoid and islet cell tumors. A review. The American journal of medicine, 1987, May-29, Volume: 82, Issue:5B Topics: Adenoma, Islet Cell; Antineoplastic Agents; Carcinoid Tumor; Dacarbazine; Drug Therapy, Combination; Humans; Malignant Carcinoid Syndrome; Neoplasm Metastasis; Pancreatic Neoplasms; Streptozocin	1987

Trials

11 trial(s) available for dacarbazine and Pancreatic Neoplasms

Article	Year
Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial. BMC cancer, 2021, Nov-12, Volume: 21, Issue:1 Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Humans; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Pilot Projects; Prospective Studies; Ramucirumab; Time Factors; Vascular Endothelial Growth Factor Receptor-2	2021
Effect of Endostar combined with chemotherapy in advanced well-differentiated pancreatic neuroendocrine tumors. Medicine, 2018, Volume: 97, Issue:45 Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Disease-Free Survival; Endostatins; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Recombinant Proteins; Temozolomide; Treatment Outcome; Vascular Endothelial Growth Factor A	2018
A prospective, phase 1/2 study of everolimus and temozolomide in patients with advanced pancreatic neuroendocrine tumor. Cancer, 2013, Sep-01, Volume: 119, Issue:17 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Prospective Studies; Sirolimus; Temozolomide; Treatment Outcome	2013
Hematological toxicity of combined 177Lu-octreotate radiopeptide chemotherapy of gastroenteropancreatic neuroendocrine tumors in long-term follow-up. Neuroendocrinology, 2014, Volume: 99, Issue:2 Topics: Adult; Aged; Anemia; Antineoplastic Agents; Blood Platelets; Capecitabine; Dacarbazine; Deoxycytidine; Digestive System Neoplasms; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Hematologic Diseases; Humans; Incidence; Intestinal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Neutrophils; Octreotide; Pancreatic Neoplasms; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Stomach Neoplasms; Temozolomide; Thrombocytopenia; Treatment Outcome	2014
Pancreatic Neuroendocrine Tumor Control: Durable Objective Response to Combination 177Lu-Octreotate-Capecitabine-Temozolomide Radiopeptide Chemotherapy. Neuroendocrinology, 2016, Volume: 103, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Dacarbazine; Female; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Temozolomide; Tomography Scanners, X-Ray Computed; Treatment Outcome	2016
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Jan-20, Volume: 24, Issue:3 Topics: Adrenal Gland Neoplasms; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Carcinoma, Islet Cell; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Pheochromocytoma; Survival Analysis; Temozolomide; Thalidomide; Treatment Outcome	2006
The systemic chemotherapy of hepatic metastases. Seminars in oncology, 1983, Volume: 10, Issue:2 Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Colonic Neoplasms; Dacarbazine; Drug Therapy, Combination; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Pancreatic Neoplasms; Rectal Neoplasms; Semustine; Stomach Neoplasms	1983
A phase II study of temozolomide in advanced untreated pancreatic cancer. Investigational new drugs, 1998, Volume: 16, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Humans; Middle Aged; Pancreatic Neoplasms; Temozolomide; Treatment Outcome	1998
Role of chemoembolization in synchronous liver metastases from pancreatic endocrine tumours. Digestive surgery, 1999, Volume: 16, Issue:1 Topics: Actuarial Analysis; Adenoma, Islet Cell; Adolescent; Adult; Aged; Aged, 80 and over; Angiography; Chemoembolization, Therapeutic; Combined Modality Therapy; Dacarbazine; Female; Follow-Up Studies; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Palliative Care; Pancreatic Neoplasms; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome	1999
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:8 Topics: Adenoma, Islet Cell; Adult; Aged; Antineoplastic Agents; Dacarbazine; Female; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Survival Analysis	2001
Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Disease Progression; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Stomach Neoplasms; Survival Analysis; Treatment Outcome	2002

Other Studies

54 other study(ies) available for dacarbazine and Pancreatic Neoplasms

Article	Year
Exceptional Responses After Cessation of Therapy With Alkylating Agents for Pancreatic Neuroendocrine Tumors. Pancreas, 2020, Volume: 49, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neuroendocrine Tumors; Outcome Assessment, Health Care; Pancreatic Neoplasms; Progression-Free Survival; Temozolomide; Withholding Treatment	2020
Short article: Evaluation of O6-methylguanine-DNA methyltransferase as a predicting factor of response to temozolomide-based chemotherapy in well-differentiated metastatic pancreatic neuroendocrine tumors. European journal of gastroenterology & hepatology, 2017, Volume: 29, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Differentiation; Dacarbazine; Disease Progression; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; France; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Patient Selection; Polymerase Chain Reaction; Precision Medicine; Predictive Value of Tests; Promoter Regions, Genetic; Retrospective Studies; Temozolomide; Time Factors; Treatment Outcome; Tumor Suppressor Proteins	2017
O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors. Pancreas, 2017, Volume: 46, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Cell Differentiation; Child; Dacarbazine; Databases, Factual; Disease Progression; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Grading; Neuroendocrine Tumors; Pancreatic Neoplasms; Pharmacogenetics; Promoter Regions, Genetic; Sequence Analysis, DNA; Temozolomide; Time Factors; Treatment Outcome; Tumor Suppressor Proteins; Young Adult	2017
Metastatic Hepatoid Carcinoma of the Pancreas: First Description of Treatment With Capecitabine and Temozolomide. The American journal of the medical sciences, 2017, Volume: 353, Issue:6 Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Biopsy; Capecitabine; Carcinoma, Hepatocellular; Dacarbazine; Glucagon; Glucagonoma; Humans; Jaundice; Liver; Male; Neoplasm Metastasis; Pancreatic Neoplasms; Prognosis; Temozolomide; Treatment Outcome	2017
Dosimetric analysis of patients with gastro entero pancreatic neuroendocrine tumors (NETs) treated with PRCRT (peptide receptor chemo radionuclide therapy) using Lu-177 DOTATATE and capecitabine/temozolomide (CAP/TEM). The British journal of radiology, 2018, Volume: 91, Issue:1091 Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Capecitabine; Case-Control Studies; Chemoradiotherapy; Dacarbazine; Drug Administration Schedule; Female; Humans; Intestinal Neoplasms; Liver; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Prospective Studies; Radiation-Sensitizing Agents; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Spleen; Stomach Neoplasms; Temozolomide; Tissue Distribution	2018
Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses. Neuroendocrinology, 2019, Volume: 108, Issue:4 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Dacarbazine; Digestive System Neoplasms; Disease-Free Survival; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Propensity Score; Temozolomide	2019
A retrospective study of capecitabine/temozolomide (CAPTEM) regimen in the treatment of metastatic pancreatic neuroendocrine tumors (pNETs) after failing previous therapy. JOP : Journal of the pancreas, 2013, Sep-10, Volume: 14, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Dacarbazine; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Fatigue; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Neutropenia; Pancreatic Neoplasms; Remission Induction; Retrospective Studies; Temozolomide; Thrombocytopenia; Time Factors; Treatment Outcome	2013
Pancreatic neuroendocrine tumors: does chemotherapy work? JOP : Journal of the pancreas, 2014, Mar-10, Volume: 15, Issue:2 Topics: Algorithms; Antineoplastic Agents; Capecitabine; Dacarbazine; Deoxycytidine; Drug Therapy; Drug Therapy, Combination; Fluorouracil; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Temozolomide; Treatment Outcome	2014
Prognostic and predictive roles of MGMT protein expression and promoter methylation in sporadic pancreatic neuroendocrine neoplasms. Neuroendocrinology, 2014, Volume: 100, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Biomarkers, Pharmacological; Biomarkers, Tumor; Dacarbazine; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Prognosis; Promoter Regions, Genetic; Temozolomide; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases	2014
Temozolomide-associated myelodysplasia 6 years after treatment of a patient with pancreatic neuroendocrine tumor. Leukemia & lymphoma, 2015, Volume: 56, Issue:8 Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Neuroendocrine Tumors; Pancreatic Neoplasms; Temozolomide; Time Factors	2015
Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy. Journal of medicinal chemistry, 2015, Sep-10, Volume: 58, Issue:17 Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Cell Proliferation; Dacarbazine; Drug Screening Assays, Antitumor; Female; Heterografts; High-Throughput Screening Assays; Humans; Isoindoles; Mice, Inbred BALB C; Mice, Nude; Microsomes, Liver; Models, Molecular; Neoplasm Transplantation; Pancreatic Neoplasms; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Rats, Sprague-Dawley; Structure-Activity Relationship; Temozolomide; Triple Negative Breast Neoplasms	2015
Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma. Journal of translational medicine, 2016, 05-03, Volume: 14, Issue:1 Topics: Administration, Metronomic; Animals; Carcinoma, Neuroendocrine; Cell Differentiation; Dacarbazine; Female; Humans; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Temozolomide; Tomography, X-Ray Computed	2016
MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors. Endocrine-related cancer, 2016, Volume: 23, Issue:8 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Dacarbazine; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Prognosis; Promoter Regions, Genetic; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins	2016
Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors. BMC cancer, 2016, 08-18, Volume: 16 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Retrospective Studies; Survival Analysis; Treatment Outcome	2016
Analysis of potential response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors. Endocrine-related cancer, 2016, Volume: 23, Issue:9 Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Co-Repressor Proteins; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Female; Humans; Male; Middle Aged; Molecular Chaperones; Neuroendocrine Tumors; Nuclear Proteins; Pancreatic Neoplasms; Telomere; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins; X-linked Nuclear Protein	2016
DNA repair enzyme expression and differential response to temozolomide in a patient with both glioblastoma and metastatic pancreatic neuroendocrine tumor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Oct-10, Volume: 26, Issue:29 Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease Progression; DNA Repair Enzymes; Fatal Outcome; Glioblastoma; Humans; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Remission Induction; Temozolomide	2008
O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Jan-01, Volume: 15, Issue:1 Topics: Antineoplastic Agents, Alkylating; Carcinoid Tumor; Dacarbazine; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; O(6)-Methylguanine-DNA Methyltransferase; Pancreatic Neoplasms; Temozolomide; Treatment Outcome	2009
[Dramatic efficacy of chemotherapy with 5-fluorouracil and dacarbazine in a patient with metastatic glucagonoma and cardiac insufficiency]. Gastroenterologie clinique et biologique, 2010, Volume: 34, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathy, Dilated; Dacarbazine; Female; Fluorouracil; Glucagonoma; Humans; Liver Neoplasms; Pancreatic Neoplasms	2010
First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas. Cancer, 2011, Jan-15, Volume: 117, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Islet Cell; Dacarbazine; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Retrospective Studies; Temozolomide; Tomography, X-Ray Computed	2011
Evaluation of the combination 5-fluorouracil, dacarbazine, and epirubicin in patients with advanced well-differentiated neuroendocrine tumors. Clinical colorectal cancer, 2010, Volume: 9, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Pancreatic Neoplasms; Retrospective Studies; Treatment Outcome	2010
Influence of cell cycle checkpoints and p53 function on the toxicity of temozolomide in human pancreatic cancer cells. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2010, Volume: 10, Issue:5 Topics: Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dacarbazine; DNA Mismatch Repair; Fibroblasts; Guanine; Humans; In Situ Nick-End Labeling; Mice; O(6)-Methylguanine-DNA Methyltransferase; Pancreatic Neoplasms; Temozolomide; Tumor Suppressor Protein p53	2010
Long-term control of a MEN1 prolactin secreting pituitary carcinoma after temozolomide treatment. Annales d'endocrinologie, 2012, Volume: 73, Issue:3 Topics: Adult; Antineoplastic Agents; Carcinoma; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Dopamine Agonists; Hormone Replacement Therapy; Humans; Hyperprolactinemia; Hypophysectomy; Hypopituitarism; Male; Multiple Endocrine Neoplasia Type 1; Mutation, Missense; Neoplasm Recurrence, Local; Ophthalmoplegia; Pancreatic Neoplasms; Parathyroid Neoplasms; Pituitary Apoplexy; Pituitary Neoplasms; Prolactin; Proto-Oncogene Proteins; Radiotherapy, Adjuvant; Remission Induction; Spinal Neoplasms; Temozolomide	2012
Targeting neuroendocrine tumor: mixing standard options with novel therapies. Targeted oncology, 2012, Volume: 7, Issue:3 Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Dacarbazine; Disease Progression; Drug Resistance, Neoplasm; Humans; Indoles; Medical Oncology; Neoplasm Metastasis; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Sunitinib; Temozolomide; Treatment Outcome	2012
Mitogen-activated protein kinase (MEK/ERK) inhibition sensitizes cancer cells to centromere-associated protein E inhibition. International journal of cancer, 2013, Feb-01, Volume: 132, Issue:3 Topics: Antineoplastic Agents; Apoptosis; Benzamides; Biomarkers, Tumor; Bridged Bicyclo Compounds, Heterocyclic; Camptothecin; Cell Line, Tumor; Cell Proliferation; Chromosomal Proteins, Non-Histone; Colonic Neoplasms; Dacarbazine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Irinotecan; Lung Neoplasms; M Phase Cell Cycle Checkpoints; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; Neuroblastoma; Pancreatic Neoplasms; RNA Interference; RNA, Small Interfering; Sarcosine; Temozolomide	2013
Temozolomide as second or third line treatment of patients with neuroendocrine carcinomas. TheScientificWorldJournal, 2012, Volume: 2012 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Dacarbazine; Disease Progression; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Ki-67 Antigen; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Prognosis; Retrospective Studies; Temozolomide	2012
Necrolytic migratory erythema in a patient with neuroendocrine carcinoma. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Capecitabine; Carcinoma, Neuroendocrine; Dacarbazine; Deoxycytidine; Diagnosis, Differential; Drug Eruptions; Female; Fluorouracil; Follow-Up Studies; Humans; Immunohistochemistry; Necrolytic Migratory Erythema; Neoplasm Staging; Pancreatic Neoplasms; Paraneoplastic Syndromes; Risk Assessment; Temozolomide; Treatment Outcome	2013
Combined liver and pancreas resection with biochemotherapy for metastatic ocular melanoma. Journal of hepato-biliary-pancreatic surgery, 2002, Volume: 9, Issue:4 Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Eye Enucleation; Female; Hepatectomy; Humans; Interferon-alpha; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Melanoma; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Uveal Neoplasms	2002
Sensitization of pancreatic tumor xenografts to carmustine and temozolomide by inactivation of their O6-Methylguanine-DNA methyltransferase with O6-benzylguanine or O6-benzyl-2'-deoxyguanosine. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Sep-01, Volume: 9, Issue:10 Pt 1 Topics: Alkylating Agents; Animals; Antineoplastic Agents, Alkylating; Carmustine; Cell Line, Tumor; Dacarbazine; Deoxyguanosine; DNA Repair; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanine; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; O(6)-Methylguanine-DNA Methyltransferase; Pancreatic Neoplasms; Temozolomide; Time Factors	2003
Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): implications to the therapy of pancreatic adenocarcinoma. Molecular cancer therapeutics, 2005, Volume: 4, Issue:9 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Blotting, Western; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Dacarbazine; Fluorouracil; Gene Expression; Gene Expression Profiling; Humans; Methionine; Neoplasm Proteins; O(6)-Methylguanine-DNA Methyltransferase; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Phosphorylation; Retinoblastoma Protein; Signal Transduction; Temozolomide; Transforming Growth Factor beta	2005
Successful management of multiple liver metastases from pancreatic neuroendocrine tumor by hepatic arterial administration of cisplatin powder. Pancreas, 2007, Volume: 35, Issue:3 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dacarbazine; Deoxycytidine; Drug Carriers; Female; Gemcitabine; Hepatic Artery; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Pancreaticoduodenectomy; Powders; Remission Induction	2007
Successful treatment of metastatic glucagonoma with dacarbazine. Lancet (London, England), 1984, Mar-17, Volume: 1, Issue:8377 Topics: Adenoma, Islet Cell; Dacarbazine; Glucagonoma; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms	1984
Malignant glucagonoma syndrome: response to chemotherapy. Annals of internal medicine, 1980, Volume: 93, Issue:3 Topics: Adenoma, Islet Cell; Dacarbazine; Female; Glucagon; Humans; Middle Aged; Pancreatic Neoplasms; Streptozocin; Syndrome	1980
Dimethyltriazenoimidazole carboxamide therapy of islet cell carcinoma of the pancreas. Journal of surgical oncology, 1981, Volume: 17, Issue:4 Topics: Adenoma, Islet Cell; Adult; Aged; Dacarbazine; Female; Glucagon; Humans; Male; Middle Aged; Pancreatic Neoplasms	1981
Operative and chemotherapeutic management of malignant glucagon-producing tumors. Surgery, 1981, Volume: 90, Issue:4 Topics: Adenoma, Islet Cell; Body Weight; Dacarbazine; Dermatitis; Diabetes Mellitus; Glucagon; Glucagonoma; Humans; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Scotoma; Syndrome	1981
Glucagonoma and dacarbazine. Annals of internal medicine, 1982, Volume: 97, Issue:6 Topics: Adenoma, Islet Cell; Dacarbazine; Glucagonoma; Humans; Pancreatic Neoplasms	1982
Therapy of malignant APUD cell tumors. Effectiveness of DTIC. Cancer, 1983, Mar-01, Volume: 51, Issue:5 Topics: Adenoma, Islet Cell; Adult; Aged; Apudoma; Carcinoid Tumor; Carcinoma; Dacarbazine; Female; Humans; Ileal Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Thyroid Neoplasms	1983
Glucagonoma and its angiographic diagnosis. Cardiovascular and interventional radiology, 1982, Volume: 5, Issue:6 Topics: Adenoma, Islet Cell; Adult; Aged; Angiography; Antineoplastic Agents; Dacarbazine; Drug Therapy, Combination; Female; Fluorouracil; Glucagonoma; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Streptozocin; Tubercidin	1982
Unsuccessful DTIC treatment of a patient with glucagonoma syndrome. Acta medica Scandinavica, 1983, Volume: 213, Issue:4 Topics: Adenoma, Islet Cell; Dacarbazine; Drug Therapy, Combination; Fluorouracil; Glucagonoma; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Streptozocin	1983
[The glucagonoma syndrome--a not-so-well-known cutaneous paraneoplastic condition. Case report]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1984, Volume: 35, Issue:4 Topics: Adenoma, Islet Cell; Adrenal Cortex Hormones; Dacarbazine; Glucagonoma; Humans; Male; Middle Aged; Pancreatic Neoplasms; Precancerous Conditions; PUVA Therapy; Skin Neoplasms; Syndrome	1984
Gut neuroendocrine tumors. Current therapy in endocrinology and metabolism, 1994, Volume: 5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Diazoxide; Etoposide; Fluorouracil; Gastrointestinal Neoplasms; Humans; Interferon-alpha; Neuroendocrine Tumors; Octreotide; Omeprazole; Pancreatic Neoplasms; Streptozocin	1994
[Paraneoplastic spastic tetraparesis in glucagonoma syndrome. Successful therapy with octreotide, dacarbazine and interferon-alpha]. Zeitschrift fur Gastroenterologie, 1996, Volume: 34, Issue:7 Topics: Adult; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Diagnostic Imaging; Glucagon; Glucagonoma; Humans; Interferon-alpha; Liver Neoplasms; Male; Octreotide; Pancreatectomy; Pancreatic Neoplasms; Paraneoplastic Syndromes; Quadriplegia	1996
Gastrinoma with multiple liver metastases: effectiveness of dacarbazine (DTIC) therapy. Journal of hepato-biliary-pancreatic surgery, 1998, Volume: 5, Issue:3 Topics: Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Gastrinoma; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Zollinger-Ellison Syndrome	1998
[Chemoembolization followed by systemic chemotherapy with dacarbazine for a metastatic glucagonoma]. Gastroenterologie clinique et biologique, 2000, Volume: 24, Issue:1 Topics: Aged; Antineoplastic Agents, Alkylating; Chemoembolization, Therapeutic; Dacarbazine; Glucagonoma; Humans; Male; Pancreatic Neoplasms	2000
Unusual presentation of Hodgkin's lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:4 Topics: Abdominal Pain; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cholangiopancreatography, Endoscopic Retrograde; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Pancreatic Neoplasms; Prognosis; Vinblastine	2002
Dimethyltriazenoimidazole carboxamide therapy of malignant glucagonoma. Annals of internal medicine, 1979, Volume: 90, Issue:1 Topics: Adult; Dacarbazine; Glucagon; Humans; Male; Pancreatic Neoplasms; Syndrome; Triazenes	1979
Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.? Surgery, gynecology & obstetrics, 1976, Volume: 142, Issue:6 Topics: Adult; Altretamine; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carmustine; Colonic Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lomustine; Lung Neoplasms; Male; Melanoma; Mitolactol; Neoplasms; Osteosarcoma; Pancreatic Neoplasms; Rectal Neoplasms; Vincristine	1976
[Glucagonoma and somatostatinoma]. Nihon rinsho. Japanese journal of clinical medicine, 1991, Volume: 49 Suppl Topics: Dacarbazine; Female; Glucagon; Glucagonoma; Glucose; Humans; Liver; Middle Aged; Octreotide; Pancreatic Neoplasms; Somatostatinoma; Streptozocin	1991
DTIC therapy in patients with malignant intra-abdominal neuroendocrine tumors. Surgery, 1987, Volume: 102, Issue:6 Topics: Abdominal Neoplasms; Adenoma, Islet Cell; Adult; Animals; Carcinoid Tumor; Dacarbazine; Female; Glucagonoma; Humans; Ileal Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Retroperitoneal Neoplasms	1987
Retrobulbar neuritis as the first sign of the glucagonoma syndrome. International ophthalmology, 1987, Volume: 11, Issue:1 Topics: Adenoma, Islet Cell; Dacarbazine; Diagnosis, Differential; Eye; Glucagonoma; Humans; Male; Middle Aged; Neuritis; Pancreatic Neoplasms; Scotoma; Vision Disorders	1987
[Metastatic glucagonoma. Complete remission by dacarbazine (5 years' recession)]. Annales de dermatologie et de venereologie, 1988, Volume: 115, Issue:8 Topics: Adenoma, Islet Cell; Dacarbazine; Follow-Up Studies; Glucagonoma; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Skin Diseases; Splenectomy	1988
A functional study of a case of glucagonoma exhibiting typical glucagonoma syndrome. Cancer, 1986, Feb-15, Volume: 57, Issue:4 Topics: Adenoma, Islet Cell; Arginine; Blood Glucose; Chromatography, Gel; Dacarbazine; Endocrine Glands; Gastric Inhibitory Polypeptide; Glucagon; Glucagonoma; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Pancreatic Neoplasms; Secretin; Somatostatin	1986
Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome. Surgery, 1986, Volume: 100, Issue:6 Topics: Adenoma, Islet Cell; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Diabetes Mellitus; Drug Evaluation; Erythema; Female; Fluorouracil; Glucagon; Glucagonoma; Humans; Liver Neoplasms; Male; Middle Aged; Octreotide; Pancreatic Neoplasms; Somatostatin; Streptozocin; Syndrome	1986
Metastatic pancreatic islet cell carcinoma causing manifestations of glucagon and gastrin hypersecretion. Connecticut medicine, 1985, Volume: 49, Issue:12 Topics: Adenoma, Islet Cell; Dacarbazine; Gastrins; Glucagon; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Zollinger-Ellison Syndrome	1985
Successful treatment of glucagonoma-related necrolytic migratory erythema with dacarbazine. Journal of the American Academy of Dermatology, 1987, Volume: 16, Issue:2 Pt 2 Topics: Adenoma, Islet Cell; Dacarbazine; Erythema; Glucagonoma; Humans; Male; Middle Aged; Pancreatic Neoplasms	1987